Prognostic Markers and Long-Term Outcomes After Aortic Valve Replacement in Patients With Chronic Aortic

Min-Seok Kim1, Jung Hwan Kim1, Hyun-Chel Joo1

  • 1Division of Cardiovascular Surgery Severance Cardiovascular HospitalYonsei University College of Medicine Seoul Korea.

Insights

Aortic valve replacement outcomes in patients with chronic aortic regurgitation depend on preoperative left ventricular (LV) function. Early diastolic transmitral flow velocity/mitral annular tissue velocity ratio predicts LV function improvement and survival, particularly in patients with reduced LV ejection fraction (LVEF).

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Echocardiography

Background:

  • Chronic aortic regurgitation (AR) can lead to left ventricular (LV) dysfunction.
  • Aortic valve replacement (AVR) is a standard treatment for severe AR.
  • Predicting outcomes after AVR in patients with pre-existing LV dysfunction is crucial.

Purpose of the Study:

  • To identify echocardiographic factors predicting improved LV systolic function post-AVR.
  • To compare long-term outcomes in chronic AR patients with or without LV dysfunction undergoing AVR.
  • To assess the role of early diastolic transmitral flow velocity/mitral annular tissue velocity ratio in predicting outcomes.

Main Methods:

  • Retrospective study of 280 chronic AR patients undergoing AVR.
  • Comparison of patients with reduced LV ejection fraction (LVEF <50%) versus preserved LVEF (≥50%).
  • Analysis of echocardiographic parameters, clinical outcomes, overall survival, and freedom from cardiac death.

Main Results:

  • Long-term survival was lower in patients with reduced LVEF compared to preserved LVEF (10-year survival: 80.1% vs. 87.3%, P=0.036).
  • Preoperative early diastolic transmitral flow velocity/mitral annular tissue velocity ratio predicted LVEF improvement post-AVR (AUC 0.719-0.726, P<0.011).
  • This ratio also predicted overall survival in all patients (HR 1.08, P=0.001) and in the reduced LVEF group (HR 1.08, P=0.005).

Conclusions:

  • Preoperative LV function is a key determinant of long-term outcomes after AVR in chronic AR.
  • Early diastolic transmitral flow velocity/mitral annular tissue velocity ratio is a valuable echocardiographic predictor of LVEF recovery and survival.
  • This ratio is particularly important for risk stratification in patients with reduced preoperative LVEF.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
213
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
212
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
184
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
166
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
153
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
131